Back to trial detailsIntake questionnaire
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Applying to Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion) · Detroit, Michigan
Answer a few short questions to share with the research team.
0 of 3 answered